Home/Filings/4/0001144204-13-065520
4//SEC Filing

Targeted Medical Pharma, Inc. 4

Accession 0001144204-13-065520

CIK 0001420030operating

Filed

Dec 3, 7:00 PM ET

Accepted

Dec 4, 2:59 PM ET

Size

8.3 KB

Accession

0001144204-13-065520

Insider Transaction Report

Form 4
Period: 2013-11-27
Giffoni Kim
DirectorEVP Foreign Sales/Inv. Rel.10% Owner
Transactions
  • Purchase

    Common Stock

    2013-11-29$1.09/sh+600$65456,341 total
  • Purchase

    Common Stock

    2013-12-02$1.05/sh+1,700$1,78558,041 total
  • Purchase

    Common Stock

    2013-11-27$1.06/sh+2,500$2,65055,741 total
Footnotes (3)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.00 to $1.07 per share.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.07 to $1.09 per share.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.03 to $1.09 per share.

Issuer

Targeted Medical Pharma, Inc.

CIK 0001420030

Entity typeoperating

Related Parties

1
  • filerCIK 0001420030

Filing Metadata

Form type
4
Filed
Dec 3, 7:00 PM ET
Accepted
Dec 4, 2:59 PM ET
Size
8.3 KB